NextGen Jane, a women's health company that is developing menstrual diagnostics for gynecological care, announced that it has received a SBIR Direct to Phase II grant from the Eunice Kennedy Shriver ...

THE Department of Public Works and Highways (DPWH) said it expects to start operations of the Central Luzon Link Expressway (CLLEX) Phase 1, connecting Subic-Clark-Tarlac Expressway (SCTEX) in Tarlac ...

A new analysis adds some clarity, finding that the Trump administration terminated $1.81 billion in National Institutes of Health grants in just over one month. Six notes: While the analysis ...

On May 1st, the Naval Sea Systems Command (NAVSEA) awarded a 5-year, SBIR Phase III contract to Rite-Solutions. This $243M contract — the largest in the history of the company — will enable ...

CEO Dan O'Connell reported that Acumen completed enrollment of its 542-participant Phase 2 ALTITUDE-AD study evaluating Sabirnetug for early Alzheimer’s disease, stating, "We completed enrollment of ...

May 8, 2025 /PRNewswire/ -- NextGen Jane, a women's health company that is developing menstrual diagnostics for gynecological care, announced that it has received a SBIR Direct to Phase II grant ...

LOS GATOS, CA – Cambrian Works announces it has been selected by SpaceWERX for a SBIR Phase II in the amount of $1,249,906.00 focused on Tactical Space Payload for Inertial De-spin Efficient ...

Sens. John Curtis, R-Utah, and Chris Coons, D-Del., members of the Small Business Committee, have proposed a bipartisan bill ...

As the inventory is set to reach close to 1 million beds by 2030, penetration rates can significantly improve from 5% to over 10% by the end of the decade, the report said. Coliving penetration ...

Corvus Phar­ma­ceu­ti­cals re­port­ed new Phase 1 da­ta in atopic der­mati­tis that sent its stock price $CRVS up by as much as … ...

noted that it's "only in the exploratory phase at this time." Pittsburgh is slated to host the NFL Draft next year, while Washington, D.C., recently secured the 2027 NFL Draft, which will be ...

Get insights into Vir Biotechnology's Q1 2025 earnings call, including ECLIPSE Phase III trial progress, oncology updates, and financial highlights.